Concepts (157)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Protein-Tyrosine Kinases | 2 | 2022 | 2423 | 0.820 |
Why?
|
Protein Phosphatase 2 | 1 | 2024 | 230 | 0.780 |
Why?
|
Proto-Oncogene Proteins | 5 | 2022 | 4520 | 0.750 |
Why?
|
Neoplasms, Muscle Tissue | 1 | 2021 | 68 | 0.730 |
Why?
|
Parvoviridae Infections | 1 | 2021 | 39 | 0.730 |
Why?
|
Anemia, Hemolytic, Autoimmune | 1 | 2021 | 147 | 0.640 |
Why?
|
Proto-Oncogene Proteins c-mdm2 | 2 | 2019 | 360 | 0.590 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 5 | 2023 | 1559 | 0.570 |
Why?
|
Oncogene Proteins, Fusion | 2 | 2024 | 1608 | 0.560 |
Why?
|
Leukemia, Myeloid, Acute | 4 | 2024 | 3640 | 0.480 |
Why?
|
Peptides, Cyclic | 1 | 2016 | 390 | 0.460 |
Why?
|
Hematopoietic Stem Cells | 1 | 2024 | 3406 | 0.370 |
Why?
|
Graft vs Host Disease | 2 | 2024 | 3078 | 0.370 |
Why?
|
Hematopoietic Stem Cell Transplantation | 3 | 2024 | 5753 | 0.360 |
Why?
|
Tumor Suppressor Protein p53 | 5 | 2019 | 2941 | 0.310 |
Why?
|
Proteins | 1 | 2021 | 5996 | 0.270 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 4 | 2017 | 1409 | 0.250 |
Why?
|
bcl-2-Associated X Protein | 2 | 2017 | 283 | 0.240 |
Why?
|
Torque teno virus | 1 | 2024 | 13 | 0.230 |
Why?
|
Whole-Body Irradiation | 1 | 2024 | 438 | 0.210 |
Why?
|
Vincristine | 3 | 2013 | 1038 | 0.200 |
Why?
|
Hemoglobins, Abnormal | 1 | 2022 | 119 | 0.200 |
Why?
|
Leukemia, Promyelocytic, Acute | 1 | 2024 | 249 | 0.200 |
Why?
|
Leukemoid Reaction | 1 | 2022 | 18 | 0.200 |
Why?
|
Plasma Cell Granuloma, Pulmonary | 1 | 2021 | 12 | 0.200 |
Why?
|
Nuclear Proteins | 1 | 2016 | 5781 | 0.190 |
Why?
|
Glucocorticoids | 2 | 2021 | 2132 | 0.190 |
Why?
|
gamma-Globins | 1 | 2022 | 105 | 0.190 |
Why?
|
Catalytic Domain | 1 | 2024 | 699 | 0.190 |
Why?
|
Anemia, Hemolytic | 1 | 2022 | 164 | 0.190 |
Why?
|
Methylation | 1 | 2024 | 1075 | 0.180 |
Why?
|
Parvovirus B19, Human | 1 | 2021 | 42 | 0.180 |
Why?
|
Apoptosis | 8 | 2019 | 9511 | 0.160 |
Why?
|
Methylprednisolone | 1 | 2021 | 386 | 0.160 |
Why?
|
Crystallography, X-Ray | 1 | 2024 | 1947 | 0.160 |
Why?
|
Antineoplastic Agents | 8 | 2019 | 13639 | 0.160 |
Why?
|
Protein Multimerization | 1 | 2024 | 959 | 0.160 |
Why?
|
Hemolysis | 1 | 2021 | 406 | 0.160 |
Why?
|
Inositol 1,4,5-Trisphosphate Receptors | 1 | 2017 | 89 | 0.140 |
Why?
|
Phenyl Ethers | 1 | 2017 | 62 | 0.140 |
Why?
|
Transplantation Conditioning | 1 | 2024 | 1635 | 0.140 |
Why?
|
Lung Neoplasms | 1 | 2021 | 13448 | 0.140 |
Why?
|
Rhabdoid Tumor | 1 | 2019 | 209 | 0.130 |
Why?
|
Child | 8 | 2024 | 80499 | 0.130 |
Why?
|
Cell Cycle Proteins | 2 | 2019 | 3431 | 0.130 |
Why?
|
Rare Diseases | 1 | 2021 | 630 | 0.130 |
Why?
|
Erythrocyte Transfusion | 1 | 2021 | 568 | 0.130 |
Why?
|
Bone Marrow Cells | 1 | 2023 | 2412 | 0.120 |
Why?
|
Doxorubicin | 5 | 2013 | 2229 | 0.120 |
Why?
|
Protein Structure, Secondary | 2 | 2015 | 1210 | 0.120 |
Why?
|
Hydrocarbons | 1 | 2015 | 105 | 0.120 |
Why?
|
Recurrence | 2 | 2024 | 8498 | 0.110 |
Why?
|
Molecular Targeted Therapy | 2 | 2024 | 2822 | 0.110 |
Why?
|
Down Syndrome | 1 | 2022 | 915 | 0.110 |
Why?
|
Neoplasms | 1 | 2022 | 22345 | 0.110 |
Why?
|
Nerve Degeneration | 1 | 2017 | 748 | 0.100 |
Why?
|
TNF-Related Apoptosis-Inducing Ligand | 1 | 2013 | 195 | 0.100 |
Why?
|
Immunologic Factors | 1 | 2021 | 1585 | 0.090 |
Why?
|
Vinca Alkaloids | 1 | 2011 | 36 | 0.090 |
Why?
|
Protein Structure, Tertiary | 2 | 2015 | 3751 | 0.090 |
Why?
|
Caspase 8 | 1 | 2011 | 198 | 0.090 |
Why?
|
Dexamethasone | 3 | 2013 | 1964 | 0.090 |
Why?
|
Anthracyclines | 1 | 2013 | 284 | 0.090 |
Why?
|
Osteosarcoma | 1 | 2016 | 909 | 0.090 |
Why?
|
Humans | 21 | 2024 | 765734 | 0.090 |
Why?
|
Paclitaxel | 1 | 2017 | 1728 | 0.080 |
Why?
|
Protein Binding | 3 | 2017 | 9299 | 0.080 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2015 | 1151 | 0.080 |
Why?
|
Axons | 1 | 2017 | 1678 | 0.080 |
Why?
|
Genotype | 1 | 2024 | 13024 | 0.080 |
Why?
|
Cell Line, Tumor | 5 | 2016 | 17062 | 0.070 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2024 | 9368 | 0.070 |
Why?
|
Mice | 9 | 2023 | 81792 | 0.070 |
Why?
|
Diagnosis, Differential | 1 | 2021 | 12949 | 0.070 |
Why?
|
Cell Differentiation | 1 | 2024 | 11641 | 0.070 |
Why?
|
Xenograft Model Antitumor Assays | 4 | 2019 | 3605 | 0.060 |
Why?
|
Bone Neoplasms | 1 | 2016 | 2564 | 0.060 |
Why?
|
Pancreatic Neoplasms | 1 | 2021 | 5442 | 0.060 |
Why?
|
DNA Damage | 1 | 2013 | 2461 | 0.050 |
Why?
|
Peptides | 1 | 2015 | 4331 | 0.050 |
Why?
|
Tumor Cells, Cultured | 3 | 2019 | 6109 | 0.050 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2019 | 8603 | 0.050 |
Why?
|
beta-Globins | 1 | 2022 | 111 | 0.050 |
Why?
|
Inflammation | 1 | 2021 | 10846 | 0.050 |
Why?
|
Animals | 9 | 2023 | 168731 | 0.050 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2024 | 3651 | 0.040 |
Why?
|
Jurkat Cells | 2 | 2012 | 737 | 0.040 |
Why?
|
Amino Acid Sequence | 3 | 2017 | 13403 | 0.040 |
Why?
|
Mice, Nude | 2 | 2019 | 3614 | 0.040 |
Why?
|
Neoplasm Transplantation | 2 | 2013 | 2011 | 0.040 |
Why?
|
Membrane Proteins | 1 | 2015 | 7849 | 0.040 |
Why?
|
Drug Synergism | 2 | 2013 | 1749 | 0.040 |
Why?
|
Adolescent | 2 | 2024 | 88781 | 0.040 |
Why?
|
Mice, Inbred NOD | 2 | 2012 | 1837 | 0.040 |
Why?
|
Mice, SCID | 2 | 2012 | 2627 | 0.030 |
Why?
|
Male | 4 | 2024 | 363585 | 0.030 |
Why?
|
Models, Molecular | 2 | 2017 | 5381 | 0.030 |
Why?
|
Central Nervous System Neoplasms | 1 | 2024 | 917 | 0.030 |
Why?
|
Heterozygote | 1 | 2022 | 2795 | 0.030 |
Why?
|
Methotrexate | 2 | 2013 | 1721 | 0.030 |
Why?
|
Deuterium Exchange Measurement | 1 | 2015 | 31 | 0.030 |
Why?
|
Ganglia, Spinal | 1 | 2017 | 528 | 0.030 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2013 | 11865 | 0.030 |
Why?
|
Antineoplastic Agents, Phytogenic | 1 | 2017 | 616 | 0.030 |
Why?
|
Drug Antagonism | 1 | 2013 | 50 | 0.030 |
Why?
|
Cyclin B | 1 | 2013 | 104 | 0.030 |
Why?
|
Cyclin E | 1 | 2013 | 155 | 0.030 |
Why?
|
Pentacyclic Triterpenes | 1 | 2012 | 39 | 0.030 |
Why?
|
Molecular Sequence Data | 2 | 2015 | 17595 | 0.020 |
Why?
|
Female | 6 | 2024 | 395961 | 0.020 |
Why?
|
HCT116 Cells | 1 | 2013 | 399 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2024 | 8528 | 0.020 |
Why?
|
Infant, Newborn | 2 | 2022 | 26332 | 0.020 |
Why?
|
Thioguanine | 1 | 2011 | 45 | 0.020 |
Why?
|
Adult | 2 | 2024 | 222974 | 0.020 |
Why?
|
Triterpenes | 1 | 2012 | 78 | 0.020 |
Why?
|
Gamma Rays | 1 | 2013 | 324 | 0.020 |
Why?
|
Infant | 2 | 2024 | 36363 | 0.020 |
Why?
|
Communication | 1 | 2024 | 3914 | 0.020 |
Why?
|
Cytarabine | 1 | 2011 | 697 | 0.020 |
Why?
|
DNA Primers | 1 | 2013 | 2823 | 0.020 |
Why?
|
Mice, Inbred Strains | 1 | 2011 | 1770 | 0.020 |
Why?
|
HeLa Cells | 1 | 2015 | 3067 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2013 | 1600 | 0.020 |
Why?
|
Mitosis | 1 | 2013 | 1172 | 0.020 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2011 | 679 | 0.020 |
Why?
|
Mass Spectrometry | 1 | 2015 | 2194 | 0.020 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2017 | 3673 | 0.020 |
Why?
|
Protein Conformation | 1 | 2015 | 3946 | 0.020 |
Why?
|
Cell Death | 1 | 2012 | 1678 | 0.020 |
Why?
|
Rats, Sprague-Dawley | 1 | 2017 | 8102 | 0.020 |
Why?
|
Binding Sites | 1 | 2015 | 6001 | 0.020 |
Why?
|
Drug Delivery Systems | 1 | 2017 | 2207 | 0.020 |
Why?
|
Drug Combinations | 1 | 2012 | 2075 | 0.020 |
Why?
|
Enzyme Activation | 1 | 2011 | 3585 | 0.020 |
Why?
|
Cell Division | 1 | 2013 | 4472 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2017 | 10730 | 0.020 |
Why?
|
Mutation | 2 | 2022 | 30184 | 0.010 |
Why?
|
Blotting, Western | 1 | 2011 | 5019 | 0.010 |
Why?
|
RNA, Small Interfering | 1 | 2013 | 3419 | 0.010 |
Why?
|
Drug Administration Schedule | 1 | 2011 | 4850 | 0.010 |
Why?
|
Cell Cycle | 1 | 2011 | 2918 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2019 | 10428 | 0.010 |
Why?
|
RNA Interference | 1 | 2011 | 2828 | 0.010 |
Why?
|
Base Sequence | 1 | 2013 | 12402 | 0.010 |
Why?
|
Drug Therapy, Combination | 1 | 2012 | 6307 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2017 | 14445 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2017 | 18972 | 0.010 |
Why?
|
Cell Survival | 1 | 2011 | 5747 | 0.010 |
Why?
|
Rats | 1 | 2017 | 23704 | 0.010 |
Why?
|
Cell Line | 1 | 2015 | 15542 | 0.010 |
Why?
|
Child, Preschool | 1 | 2024 | 42468 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2017 | 22321 | 0.010 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2013 | 5336 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2024 | 65180 | 0.010 |
Why?
|
Middle Aged | 1 | 2024 | 222903 | 0.010 |
Why?
|
Signal Transduction | 1 | 2011 | 23589 | 0.000 |
Why?
|
Concepts
(157)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(44)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_